White House Chief of Staff Susie Wiles remains in her role past the March 31 deadline, driving trader consensus to 100% on "No" as no official resignation, firing, or departure has occurred. Her mid-March announcement of an early-stage breast cancer diagnosis, coupled with statements from President Trump and Wiles affirming she would continue working virtually full-time, quelled speculation amid prior rumors of post-midterm exit plans. High confidence reflects the absence of any verified White House personnel changes or public statements indicating a shift, consistent with her steady tenure since the 2025 inauguration. Realistic scenarios for reversal—such as sudden health complications, internal administration realignment, or disputed resolution criteria—appear improbable given current reporting.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · AktualisiertJa
$28,874 Vol.
$28,874 Vol.
Ja
$28,874 Vol.
$28,874 Vol.
An announcement of Wiles' resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from the Trump administration; however, a consensus of credible reporting may also be used.
Markt eröffnet: Dec 16, 2025, 2:26 PM ET
Resolver
0x65070BE91...Vorgeschlagenes Ergebnis: Nein
Einspruchsfrist
Endgültig
An announcement of Wiles' resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from the Trump administration; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Vorgeschlagenes Ergebnis: Nein
Einspruchsfrist
Endgültig
White House Chief of Staff Susie Wiles remains in her role past the March 31 deadline, driving trader consensus to 100% on "No" as no official resignation, firing, or departure has occurred. Her mid-March announcement of an early-stage breast cancer diagnosis, coupled with statements from President Trump and Wiles affirming she would continue working virtually full-time, quelled speculation amid prior rumors of post-midterm exit plans. High confidence reflects the absence of any verified White House personnel changes or public statements indicating a shift, consistent with her steady tenure since the 2025 inauguration. Realistic scenarios for reversal—such as sudden health complications, internal administration realignment, or disputed resolution criteria—appear improbable given current reporting.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen